Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing PRP, PRF, and standard treatment for chronic skin ulcers

Official title: Efficacy of Platelet-rich Plasma Versus Platelet-rich Fibrin Versus Conventional Treatment in Chronic Non-healing Skin Ulcers: a Comparative Study

Run by Kafrelsheikh University · NCT06281483 · Data updated 2026-11-12

This study is testing if two new treatments for chronic skin ulcers, PRP and PRF, work better than standard care for helping wounds heal.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment36 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedJanuary 1, 2026
Study endsJanuary 2026
Registry record updatedMarch 5, 2025
Trial IDNCT06281483 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with chronic cutaneous ulcers that have persisted for over six weeks and are between 0.5 and 10 cm in size.

Probably not a fit

Patients with bleeding disorders, uncontrolled diabetes, active infections, or those who are pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of two newer treatments, platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), in comparison to conventional methods for managing chronic non-healing skin ulcers. Chronic ulcers are defined as wounds that do not heal within six weeks despite appropriate treatment, affecting millions of individuals, particularly the elderly and diabetic populations. The study will involve patients with ulcers of varying sizes and durations, assessing the healing outcomes of the different treatment modalities. The interventions will include surgical debridement, normal saline washing, and dressing coverage alongside the experimental treatments.

Why it matters

Potential benefit: If successful, this study could provide more effective treatment options for patients suffering from chronic non-healing skin ulcers.

How similar studies have gone: While the use of PRP and PRF in wound healing has shown promise in preliminary studies, this specific comparison against conventional treatments is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting with cutaneous ulcers greater than six weeks of duration and a size ranging between 0.5 and 10 cm, having a normal platelet count and hemoglobin \>10 gm%.

Exclusion Criteria:

* Patients with known bleeding disorders, and/or on oral anticoagulant therapy, uncontrolled diabetes, proven malignancy.
* Patients who are pregnant or lactating.
* Patients with actively infected ulcers, clinically defined by purulent discharge, green discoloration or fever, or positive culture, ulcers with exposed bone with no underlying granulation tissue, HIV, HCV, HBV patients.
* Patients who are with unrealistic expectations and unwilling to give consent for treatment or photography.

Where it's running

  • Badr Hospital - Helwan University and Kafrelseikh University Hospital
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.